サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1634165

医療シミュレーションの世界市場 - 2025～2033年

Global Medical Simulation Market - 2025 - 2033

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療シミュレーションの世界市場 - 2025～2033年
出版日: 2025年01月13日
発行: DataM Intelligence
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療シミュレーションの世界市場は、2024年に24億米ドルに達し、2033年には94億米ドルに達すると予測され、予測期間2025年～2033年のCAGRは16.4%で成長すると予測されています。

医療シミュレーションとは、ヘルスケアにおけるトレーニング、教育、評価、研究を目的として、現実の医療シナリオ、手順、環境を再現するために高度なツール、技術、テクノロジーを体系的に使用することです。医療従事者が、実際の患者に危険を及ぼすことなく、臨床スキル、意思決定、チームワーク、コミュニケーションを練習できるような、現実的で、インタラクティブで、管理された環境を作り出すことです。医療シミュレーションは、実際の病状、解剖学的構造、生理学的反応、臨床環境を反映するよう努めます。これは、物理的な模型（マネキン）から没入型のデジタル環境（バーチャルリアリティ）まで様々です。

医療シミュレーション市場は、技術の進歩、患者の安全性重視の高まり、低侵襲治療への需要の高まりによって大きな成長を遂げています。医療教育機関の拡大により、学生に実践的なトレーニングを提供するシミュレーションツールの需要が高まっています。

例えば、World Directory of Medical Schoolsによると、世界195カ国に約3,965の医科大学 / 医科学校があります。これら3,965校のうち、アジア48カ国に1,865校（47%）、ラテンアメリカ33カ国に894校（23%）、欧州44カ国に559校（14%）、アフリカ54カ国に368校（9%）、北米（米国とカナダ）に215校（5%）、オーストラリアとニュージーランドを含むオセアニア14カ国に38校（1%）の医学部があります。

市場力学：

促進要因と抑制要因

医療シミュレーションにおける技術進歩の高まり

医療シミュレーションにおける技術進歩の高まりは、医療シミュレーション市場の成長を大きく後押ししており、予測期間中も市場を牽引すると予測されます。仮想現実（VR）および拡張現実（AR）技術は、医療専門家が高度な機能を備えた管理された環境で外科手術の練習や病気の診断、緊急事態の管理などを行うことができる、高度にインタラクティブで没入感のある環境の構築を可能にします。

例えば、VRAD Co., Ltd.は2024年11月、韓国で広く認知されている2つのバーチャルリアリティベースのシミュレーター、看護技術教育シミュレーターNS_Coreと外傷患者ケアシミュレーターIP_Traumaを国際市場向けに発売しました。これらの製品は、韓国語、英語、ベトナム語、タイ語、インドネシア語、中国語、日本語、カザフ語、ドイツ語など幅広い言語に対応しており、年内にはスペイン語とフランス語のサポートも予定されています。

さらに、2023年6月には、蘇生、患者ケア、救急医療トレーニングの分野でシミュレーションベースのトレーニングを提供するレールダル・メディカル社と、仮想現実（VR）医療シミュレーションプラットフォームを提供するSimX社が提携し、医療従事者が最適なケアを提供できるよう準備するVRシミュレーショントレーニングソリューションで患者の安全性向上を支援すると発表しました。

AIを搭載したシステムは、受講者のパフォーマンスを分析し、個別のフィードバックを提供することで、特定のスキルの向上を支援します。また、AIを活用したシミュレーションはリアルタイムに適応し、受講者の過去の反応に基づいて新しいシナリオを作成し、学習体験を向上させることができます。AIは医療シミュレーションの評価を自動化し、訓練生のスキルをより正確かつ客観的に評価するために利用されています。

例えば、2023年10月、LumetoはInvolveXRプラットフォームの画期的なAIアップグレードを発表しました。InvolveXRは完全没入型で柔軟性の高いXRシミュレーションラボであり、ヘルスケア分野での没入型トレーニングや評価の導入を検討している医療機関向けです。このプラットフォームには、Large Language Model（LLM）ベースのAI主導のカスタマイズ可能な会話システムが搭載されており、仮想患者との出会いをシミュレートする上で、これまでにないレベルの適応性を実現しています。

医療シミュレーターの高コスト

医療シミュレータに関連する高コストは、医療シミュレーション市場の成長を妨げると予想されます。この技術は医療従事者のトレーニングに非常に効果的であることが証明されていますが、価格が高いため、特に小規模のヘルスケア施設や教育機関、リソースの少ない環境では普及が進みません。例えば、Healthy Simulation社によると、ヒト患者シミュレータの価格は、種類、ブランド、機能、含まれるサポートサービスにもよりますが、通常1万米ドルから10万米ドル程度です。

さらに、様々な病状をシミュレートする高忠実度のマネキンは、購入だけでなくメンテナンスやキャリブレーションにも多額の投資が必要です。例えば、基本的な患者シミュレーターは20,000米ドルから40,000米ドルであるのに対し、フル機能を備えたより高度なシステムは250,000米ドルを超えることもあります。

シミュレータは高額であるため、教育機関では限られた台数しか購入できず、シミュレーションに基づくトレーニングの恩恵を受けられる学生やヘルスケア専門家の数が制限される可能性があります。これは、医療シミュレーションプログラムの全体的な効果を低下させ、普及の妨げとなります。医学部では、限られた台数のシミュレータでは一度に少人数の学生しかトレーニングできない可能性があり、学習プロセスの有効性が低下し、部門全体への広範な導入が遅れます。

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • 製品タイプ別抜粋
  • テクノロジー別抜粋
  • 用途別抜粋
  • エンドユーザー別抜粋
  • 地域別抜粋

第3章 市場力学

  • 影響要因
    • 促進要因
      • 医療シミュレーションにおける技術進歩の高まり
    • 抑制要因
      • 医療シミュレーターの高コスト
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名な企業
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 医療シミュレーション市場、製品タイプ別

  • 患者シミュレータ
  • 介入 / 外科シミュレータ
  • 血管内シミュレータ
  • 超音波シミュレータ
  • 診断シミュレータ
  • その他

第6章 医療シミュレーション市場、テクノロジー別

  • 仮想患者シミュレーション
  • 3Dプリント
  • 手順リハーサル技術

第7章 医療シミュレーション市場、用途別

  • 医療研修
  • 外科研修
  • 患者ケアと管理
  • その他

第8章 医療シミュレーション市場、エンドユーザー別

  • 病院
  • 軍事組織
  • 医学大学
  • 看護学校
  • 専門クリニック

第9章 医療シミュレーション市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • CAE Inc.
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • 3D Systems, Inc.
  • Simulab Corporation
  • Kyoto Kagaku Co., Ltd.
  • Laerdal Medical
  • 3B Scientific
  • Biomed Simulation, Inc.
  • Cardionics Inc.
  • Gaumard Scientific
  • Simulaids

第12章 仮定と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第13章 付録

目次
Product Code: MD1362

The global medical simulation market reached US$ 2.4 billion in 2024 and is expected to reach US$ 9.4 billion by 2033, growing at a CAGR of 16.4% during the forecast period 2025-2033.

Medical simulation is the systematic use of advanced tools, techniques and technologies to replicate real-life medical scenarios, procedures and environments for the purpose of training, education, assessment, and research in healthcare. It involves creating realistic, interactive, and controlled settings that allow healthcare professionals to practice clinical skills, decision-making, teamwork, and communication without posing risks to real patients. Medical simulation strives to mirror actual medical conditions, anatomy, physiological responses, and clinical environments. This can range from physical models (mannequins) to immersive digital environments (virtual reality).

The medical simulation market experiencing significant growth driven by technological advancements, an increasing emphasis on patient safety and the rising demand for minimally invasive treatments. The expansion of medical education institutions has led to a higher demand for simulation tools to provide hands-on training to students.

For instance, there are approximately 3,965 medical colleges/schools in 195 countries in the world as per the World Directory of Medical Schools. Out of these total 3,965 medical colleges, Asia 48 countries have 1,865 (47%) medical colleges, Latin America 33 countries have 894 (23%) medical colleges, Europe 44 countries have 559 (14%) medical colleges, Africa 54 countries have 368 (9%) medical colleges, North America (USA and Canada) have 215 (5%) medical schools, Oceania 14 countries including Australia and New Zealand have 38 (1%) medical schools.

Market Dynamics: Drivers & Restraints

Rising technological advancements in medical simulation

The rising technological advancements in medical simulation are significantly driving the growth of the medical simulation market and are expected to drive the market over the forecast period. Virtual Reality (VR) and Augmented Reality (AR) technologies enable the creation of highly interactive, immersive environments where medical professionals can practice surgical procedures, diagnose diseases, or manage emergency situations in a controlled setting with advanced features.

For instance, in November 2024, VRAD Co., Ltd. launched two widely recognized Korean-developed virtual reality-based simulators, NS_Core, a nursing skills education simulator, and IP_Trauma, a trauma patient care simulator, for international markets. These products support a broad range of languages, including Korean, English, Vietnamese, Thai, Indonesian, Chinese, Japanese, Kazakh, and German, with Spanish and French language support anticipated by the end of the year.

Additionally, in June 2023, Laerdal Medical, a provider of simulation-based training in the fields of resuscitation, patient care, and emergency care training, and SimX, a virtual reality (VR) medical simulation platform, announced a partnership to help increase patient safety with a VR simulation training solution that prepares providers to deliver optimal care.

AI-powered systems can analyze the performance of trainees and provide personalized feedback, helping them improve specific skills. AI-driven simulations can also adapt in real-time, creating new scenarios based on the learner's previous responses, enhancing the learning experience. AI is being used to automate the assessment of medical simulations, offering more accurate and objective evaluations of a trainee's skills.

For instance, in October 2023, Lumeto announced a landmark AI upgrade to its InvolveXR platform. InvolveXR is a fully immersive and highly flexible XR Simulation Lab for institutions looking to deploy immersive training and assessment across the healthcare spectrum. The platform is equipped with a Large Language Model (LLM) based AI-driven customizable conversational system enabling an unprecedented level of adaptability for simulating virtual patient encounters.

High cost associated with the medical simulators

The high cost associated with medical simulators is expected to hamper the growth of the medical simulation market. While the technology has proven to be highly effective in training healthcare professionals, its high price point prevents widespread adoption, particularly in smaller healthcare facilities, educational institutions, and low-resource settings. For instance, according to Healthy Simulation, a human patient simulator typically ranges in price from $10,000 to $100,000 depending on the type, brand, features and included support services.

Additionally, high-fidelity mannequins that simulate various medical conditions require significant investment not just in purchasing but also in maintenance and calibration. For instance, a basic patient simulator can range from USD 20,000 to USD 40,000, while more advanced systems with full functionality can exceed USD 250,000.

Due to the high cost of simulators, institutions may only be able to purchase a limited number of units, restricting the number of students or healthcare professionals who can benefit from simulation-based training. This reduces the overall impact of medical simulation programs and hinders widespread adoption. In a medical school, a limited number of simulators may only allow a small group of students to train at a time, reducing the effectiveness of the learning process and delaying broader adoption across departments.

Segment Analysis

The global medical simulation market is segmented based on product type, technology, application, end-user and region.

Product Type:

The patient simulators segment is expected to dominate the medical simulation market share

Patient simulators can be used in a wide variety of medical specialties, including emergency care, surgery, anesthesiology, and obstetrics. Their versatility allows medical institutions to train professionals across many disciplines using the same tool, making them a popular choice. Patient simulators allow trainees to practice rare or complex cases without risk to actual patients, improving skills and decision-making. This focus on patient safety has made them a go-to tool for hospitals and medical schools aiming to reduce medical errors.

For instance, in February 2024, IngMar Medical released Aurora, a medical simulation manikin used to train clinicians in all forms of ventilation. Aurora's new Internal Simulated Lung (ISL) is based on the IngMar's ASL 5000 Breathing Simulator technology. The technology elevates medical training by offering a tetherless, internal system that interacts realistically with all forms of ventilation including bag-valve masks, noninvasive, and invasive ventilation.

Manufacturers are constantly improving the capabilities of patient simulators, incorporating advanced features such as artificial intelligence and real-time feedback. These innovations increase the effectiveness of training programs and further boost the segment's dominance.

For instance, in October 2024, YouMakr.ai, a leader in artificial intelligence solutions for medical education, launched its latest innovation: the AI Patient Simulator. This cutting-edge tool is designed to enhance medical training by automatically generating realistic patient scenarios, allowing medical students to practice and apply their theoretical knowledge in a more efficient and engaging manner.

Geographical Analysis

North America is expected to hold a significant position in the medical simulation market share

North America especially the United States and Canada known for its major market players and also leads in the development and integration of innovative simulation technologies, such as virtual reality (VR), augmented reality (AR), and artificial intelligence (AI). These technologies enable highly realistic simulations that are essential for medical training.

For instance, in July 2023, Hard Hat VR, a leading provider of virtual reality (VR) training simulations, and MindWise Innovations, an award-winning service of the non-profit Riverside Community Care that provides evidence-based mental health and substance use services, announced their strategic partnership to develop an innovative suite of VR training simulations focused on mental health in the workplace.

The demand for medical simulation tools is substantial due to the region's focus on reducing medical errors, enhancing patient safety, and improving healthcare outcomes. Simulation-based education is increasingly being adopted to train healthcare professionals in realistic, risk-free environments.

For instance, in January 2024, Simulab Corporation unveiled its latest technology, SimuSkin. This announcement marks a significant milestone in the company's history, showcasing its dedication to advancing the realism and efficacy of healthcare simulation in medical education. SimuSkin is the result of Simulab's persistent efforts in research and development. SimuSkin has been meticulously designed to emulate human tissue with accuracy in appearance, feel, tactile, and surgical response. This advancement not only sets a new benchmark for realism but also ensures longevity and material integrity, elevating the standard of medical simulation.

Asia-Pacific is growing at the fastest pace in the medical simulation market

The Asia-Pacific region faces a significant need to train a growing number of healthcare professionals, as the region deals with a rapidly increasing population, aging demographics, and evolving healthcare demands. Simulation-based training has emerged as a vital tool for equipping healthcare professionals with the necessary skills and knowledge, as it allows hands-on practice in a risk-free environment.

For instance, in July 2024, MediSim VR publicized Chennai's 'first' immersive and interactive VR-training lab at Sri Ramachandra Institute of Higher Education and Research (SRIHER). The virtual reality technology has benefitted more than 4,000 students, enabling what the healthcare simulation training solutions provider MediSim VR describes as "unparalleled access to immersive, hands-on medical training". It offers students realistic medical scenario simulations within a safe environment to help boost procedural competency, skills, and confidence.

Simulation provides a safe and controlled environment for healthcare providers to practice and refine their skills, thereby minimizing the chances of medical errors in real-life scenarios. With increasing patient awareness and expectations for high-quality care in the Asia-Pacific, especially in China, India and Japan, healthcare institutions are turning to simulation to improve competency among medical professionals.

For instance, in December 2024, Fujifilm India introduced the mikoto Colon Model, a groundbreaking endoscopy simulator, during the Indian Association of Gastrointestinal Endosurgeons (IAGES) Prof. Dr. B Krishna Rau Simulation Training Programme in Chennai. This innovative technology reaffirms Fujifilm's commitment to enhancing medical education and improving healthcare outcomes in India. The mikoto Colon Model is a cutting-edge simulation tool that transforms endoscopy training. Its compact and portable design integrates advanced sensors and artificial intelligence, delivering realistic feedback, performance evaluations, and procedural scoring. By fostering precision and confidence, the mikoto Colon Model equips healthcare professionals to provide superior endoscopic care, ultimately benefiting patients.

Competitive Landscape

The major global players in the medical simulation market include CAE Inc., 3D Systems, Inc., Simulab Corporation, Kyoto Kagaku Co., Ltd., Laerdal Medical, 3B Scientific, Biomed Simulation, Inc., Cardionics Inc., Gaumard Scientific, Simulaids and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical simulation market report delivers a detailed analysis with 70 key tables, more than 68 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements in Medical Simulation
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost Associated with the Medical Simulators
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics

5. Medical Simulation Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Patient Simulators*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Interventional/Surgical Simulators
  • 5.4. Endovascular Simulators
  • 5.5. Ultrasound Simulators
  • 5.6. Diagnostic Simulators
  • 5.7. Others

6. Medical Simulation Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Virtual Patient Simulation*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. 3D Printing
  • 6.4. Procedure Rehearsal Technology

7. Medical Simulation Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Medical Training*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Surgical Training
  • 7.4. Patient Care and Management
  • 7.5. Others

8. Medical Simulation Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Military Organizations
  • 8.4. Medical Universities
  • 8.5. Nursing Schools
  • 8.6. Specialty Clinics

9. Medical Simulation Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. CAE Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. 3D Systems, Inc.
  • 11.3. Simulab Corporation
  • 11.4. Kyoto Kagaku Co., Ltd.
  • 11.5. Laerdal Medical
  • 11.6. 3B Scientific
  • 11.7. Biomed Simulation, Inc.
  • 11.8. Cardionics Inc.
  • 11.9. Gaumard Scientific
  • 11.10. Simulaids

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us